Skip to main content

Table 5 Treatment outcomes among the studied groups according to RT-PCR results

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Treatment outcomes

Total cases (No. = 280)

Total (n = 280)

χ2 test and P value

Group I (n = 140),

Group II (n = 80)

Group III (n = 60),

No.

%

No.

%

No.

%

No.

%

Responder/SVR (No. = 260)

130

92.9

70

87.5

60

100

260

92.9

Test = 3.56

P = 0.47

Non-responder (No. = 10)

10

7.1

0

0.0

0

0.0

10

3.6

Relapse (No. = 10)

0

0.0

10

12.5

0

0.0

10

3.6